Beijing LDK Technology Co., Ltd.

Established in 1998, Beijing LDK Technology Co., Ltd. is a professional company,dedicating to R&D, production and distribution of surgical implants- joint prosthesis. LDK had been initiated by Yingchen Xu, an expert of old generation and senior engineer, who researched and developed joint prosthesis in the former Iron and Steel Research Institute. In the initial stage of establishment, Xu joined with Shibi Lu, academician of the PLA General Hospital, and Jifang Wang, tutor of doctorial students, developed domestic joint prosthesis state-of-the-art, received multiple country-level prize of scientific & technical progress, and laid a solid foundation for LDK to grow into a national brand emphasizing quality, research and technology. After twenty years of accumulation, deposition and frequent progress, LDK has developed into a modernized hi-tech producer. The Company processes Class III product production license of medical equipment, business operation license, multiple product registration certificates including hip, knee and tumor joint, and has passed ISO 9001:2015 and ISO 13485:2016 and CE approval. Over the years, with its own technical strength, LDK has cooperated with famous orthopaedic experts and professors in many hospitals in China, and developed a variety of ambassadors suitable for the Chinese people with advanced design concepts. We have accumulated abundant technical experience in joint products, especially in the research and development and manufacture of cancer products. At present, Lidakang has 14 national product patents, 4 registered copyright of instruments, and many international patents are being applied for. As one of the oldest manufacturer of artificial joints in China, Lidakang attaches great importance to the social responsibility of enterprises. Over the years, Lidakang has continuously participated in various social welfare undertakings, and has been recognized and praised by all parties for its excellent product quality.

• Employees 500
• Founded 1998
• Total Funding $16350300